Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Discussion - Public policy

5003 - Measuring the cancer burden in Europe: the European Cancer Information System (ECIS)

Date

29 Sep 2019

Session

Poster Discussion - Public policy

Presenters

Manola Bettio

Citation

Annals of Oncology (2019) 30 (suppl_5): v671-v682. 10.1093/annonc/mdz263

Authors

M. Bettio, R.N. Carvalho, N. Dimitrova, T. Dyba, M. Flego, F. Giusti, C. Martos, L. Neamtiu, N. Nicholson, G. Randi, C. Nicholl

Author affiliations

  • Directorate F Health, Consumers And Reference Materials, Health In Society Unit, European Commission – Joint Research Centre, 21027 - Ispra/IT

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 5003

Background

The European Commission has a long-term commitment to reducing cancer burden in the EU. Evaluation of the effectiveness of measures implemented is dependent on accurate and comparable data allowing derivation of cancer indicators (incidence, mortality, survival). For this purpose, the EC Joint Research Centre (JRC) in close collaboration with DG SANTE is maintaining a comprehensive cancer information system for Europe.

Methods

Population-based cancer registries (CRs) are the information source for the computation of cancer burden indicators. In response to the call from the Council to the Commission to act further in harmonising EU cancer registration, the JRC since 2012 has taken an active role in supporting the activities and exploiting the data of the CRs affiliated to the European Network of Cancer Registries (ENCR).

Results

The JRC has developed and launched in February 2018 the European Cancer Information System (ECIS) as a web-based tool to report and disseminate cancer burden indicators. The ECIS displays historical time series and projections of cancer incidence and mortality, as well as cancer survival indicators. Statistics in the ECIS are derived from the data of about 150 CRs in 34 European countries, detailing up to 58 cancers sites. The database feeding the ECIS is dynamic and is updated as new data become available.

Conclusions

ECIS permits the exploration of geographical patterns and temporal trends of cancer burden indicators at national and/or regional level. It constitutes an essential tool to promote awareness on cancer burden, to assess and monitor its magnitude and follow trends and changes over time. ECIS is an important step forward in informing the citizens, assisting political decision making and supporting epidemiological research.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

European Commission.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.